Gabapentin Titration Guidelines

Introduction to Gabapentin Titration

The American Academy of Neurology recommends increasing gabapentin dose by 300mg daily every 3-7 days until reaching 1800mg/day (600mg three times daily), then continuing titration by 300mg daily increments every 3-7 days as tolerated up to a maximum of 3600mg/day (1200mg three times daily) 1

The standard therapeutic range for gabapentin is 1800-3600mg/day in three divided doses, with a minimum effective dose of 1800mg/day (600mg TID) and a maximum dose of 3600mg/day (1200mg TID) 1, 2

Three times daily dosing is mandatory for gabapentin due to nonlinear, saturable absorption pharmacokinetics, making once or twice daily dosing ineffective 1, 2
Slower titration for elderly/frail patients is recommended, using the longer end of the 3-7 day interval (every 5-7 days) to minimize dizziness and fall risk 1, 2

The minimum trial period for gabapentin is 3-8 weeks for titration PLUS 2 weeks at maximum tolerated dose, and an adequate therapeutic trial may require 2 months or more before declaring treatment failure 1, 2

The Mayo Clinic recommends not rushing titration in elderly patients, as it increases fall risk from dizziness, and to use every 5-7 day intervals 1, 2
The American Academy of Neurology recommends not discontinuing gabapentin abruptly, but to taper gradually over at least 1 week to avoid withdrawal symptoms 2
The Mayo Clinic recommends not declaring treatment failure prematurely, but to allow the full 2-month trial period as efficacy develops gradually 1, 2
The American Academy of Neurology recommends not using once or twice daily dosing for gabapentin, as three times daily administration is essential due to saturable absorption 1, 2